Pierre Armand Morgon
Vorsitzender bei EUROCINE VACCINES AB
Vermögen: 20 066 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Pierre Armand Morgon
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy.
23
| Operating Division | Investment Managers | 23 |
| Public Company | Pharmaceuticals: Major | 18 | |
12
| Public Company | Household/Personal Care | 12 |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium.
10
| Holding Company | Biotechnology | 10 |
| Public Company | Pharmaceuticals: Major | 9 | |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Adiposs SA
 Adiposs SA Medical SpecialtiesHealth Technology Adiposs SA is a Swiss medical imaging company that has developed imagebat-enhanced CT scan technology. The company is based in Plan-les-Ouates, Switzerland. The technology is fast, pain-free, and can be made available in every hospital and organization worldwide that provides CT scans. The company's co-inventor, Andrej Babic, has co-authored more than 30 scientific papers and holds several patents in the fields of medical imaging, photodynamic therapy, and nanotechnology. The company's team includes experts in preclinical development, clinical trials, and drug development across multiple therapeutic areas. Adiposs was founded by Nathalie Stransky-Heilkron, Andrej Babic, and Justyna Plewka Ma. Andrej Babic has been the CEO since incorporation.
5
| Holding Company | Medical Specialties | 5 |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France.
5
| Subsidiary | Biotechnology | 5 |
Kupando GmbH
 Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018.
2
| Holding Company | Biotechnology | 2 |
Health Technology Holding Srl
 Health Technology Holding Srl Investment ManagersFinance Health Technology Holding Srl (HTC), is a venture capital subsidiary of Gefim SpA founded in 2019. The firm is headquartered in Milan, Italy.
2
| Subsidiary | Investment Managers | 2 |
Schering-Plough SAS
 Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
| Public Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Pierre Armand Morgon
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of Bari | College/University | Doctorate Degree Undergraduate Degree | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Director of Finance/CFO | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Masters Business Admin Corporate Officer/Principal | |
| University of Toronto | College/University | Doctorate Degree Doctorate Degree | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Director of Finance/CFO | |
| Trinity College Dublin | College/University | Graduate Degree Doctorate Degree | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Astra Pharmaceuticals AB | Corporate Officer/Principal Corporate Officer/Principal | ||
| EM Lyon Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
| Université Claude Bernard Lyon 1 | College/University | Graduate Degree Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| The LUISS University of Rome | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Lyon | College/University | Doctorate Degree Doctorate Degree | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Università degli Studi di Napoli Federico II | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Luiss Business School | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member | |
Bio City Development Co. BV
 Bio City Development Co. BV Medical/Nursing ServicesHealth Services Bio City Development Co. BV provides healthcare services. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
Global Health Investment Fund
 Global Health Investment Fund Investment ManagersFinance Global Health Investment Fund seeks investment opportunities in global health technologies. The fund invests in new drugs & vaccines, emerging diagnostic tools, child-friendly formulations of existing products, expanding manufacturing capacity and other applications. It provides financing in the form of mezzanine for later-stage capital requirements. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| SDA Bocconi School of Management | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| IDOGEN AB (PUBL) | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| NANEXA AB | Medical Specialties | Chairman Chairman | |
| ALTIMMUNE, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Pharmaceuticals: Generic | Director/Board Member | |
| Zipprime Ltd. | Founder Consultant / Advisor | ||
Johnson & Johnson Medical SAS
 Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical SAS is a French company that wholesales pharmaceutical products. The company is based in Issy-les-Moulineaux, France. The CEO of the company is Myriam Martinez Climent. | Medical Distributors | Corporate Officer/Principal | |
Frontier Nutrition, Inc.
 Frontier Nutrition, Inc. Food: Specialty/CandyConsumer Non-Durables Frontier Nutrition, Inc. develops and manufactures fortified packaged food. Its recipes are localized for traditional diets, taste, and nutrition. The company was founded by Eddie Bearnot and Tanveer Ali on August 18, 2016 and is headquartered in DE. | Food: Specialty/Candy | Director/Board Member | |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Founder Founder | |
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Université Paris-Saclay | College/University | Doctorate Degree | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Quantoom Biosciences SA
 Quantoom Biosciences SA Pharmaceuticals: OtherHealth Technology Quantoom Biosciences SA is a Belgian company that is focused on revolutionizing mRNA production through the development of their platform, ntensify. The private company is based in Nivelles, Belgium. This platform includes DNA amplification and RNA manufacturing, with the ntensify systems being the core of their RNA production technology. The company is made up of a team of scientists, engineers, and clinicians who are dedicated to addressing the major challenges in DNA and RNA production for vaccines and therapeutics. | Pharmaceuticals: Other | Director/Board Member | |
| Ulysses Advisory Group LLP | Founder Founder | ||
| CUBE LABS S.P.A. | Investment Managers | Corporate Officer/Principal Chief Executive Officer Director/Board Member Corporate Officer/Principal Chief Operating Officer Public Communications Contact Director of Finance/CFO |
Statistik
International
| Vereinigte Staaten | 11 |
| Frankreich | 11 |
| Schweden | 11 |
| Italien | 7 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 19 |
| Consumer Services | 18 |
| Commercial Services | 5 |
| Finance | 5 |
| Distribution Services | 3 |
Operativ
| Director/Board Member | 305 |
| Corporate Officer/Principal | 145 |
| Chairman | 105 |
| Chief Executive Officer | 67 |
| Founder | 60 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Rémi Droller | 29 |
| Didier Hoch | 24 |
| Michael Wolff Jensen | 23 |
| Yossi Bornstein | 22 |
| Karen Dawes | 22 |
| Timothy Morris | 21 |
| Jan Nils Sandström | 20 |
| Glenn Rockman | 17 |
| Mikael Oerum | 17 |
| Lena Birgitta Degling Wikingsson | 16 |
| Lucian Wagner | 16 |
| Neil Thomas | 16 |
| Ferran Prat | 15 |
| Sylvie Guinard | 14 |
- Börse
- Insiders
- Pierre Armand Morgon
- Unternehmensverbindungen
